General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Pfizer(MODEST) RESEARCH/RESEARCH GRANTS: Amgen(MODEST), Novartis Corporation(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Esperion(SIGNIFICANT), DalCor(SIGNIFICANT), Sanofi Aventis(SIGNIFICANT), Medscape(MODEST)